Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma

Glioblastoma (GB) remains the most fatal brain tumor characterized by a high infiltration rate and treatment resistance. Overexpression and/or mutation of receptor tyrosine kinases is common in GB, which subsequently leads to the activation of many downstream pathways that have a critical impact on...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolcaen, Julie, Nair, Shankari, Driver, Cathryn H. S., Boshomane, Tebatso M. G., Ebenhan, Thomas, Vandevoorde, Charlot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308832/
https://www.ncbi.nlm.nih.gov/pubmed/34209513
http://dx.doi.org/10.3390/ph14070626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308832/
https://www.ncbi.nlm.nih.gov/pubmed/34209513
http://dx.doi.org/10.3390/ph14070626

Ejemplares similares